Vaxart Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -64.2% | -62.2% | -37.2% | -28.8% | +137.1% | -59.0% | -78.0% | -88.0% | +6,796.3% | +288.9% | +726.7% | |
| – | -93.0% | -97.2% | +12,255.0% | +39.8% | -15.8% | +36.6% | +145.4% | -93.3% | +37.7% | -2.2% | – | |
| – | +19.3% | -56.2% | -170.8% | – | – | -260.4% | – | – | +2,590.7% | +896.9% | +726.7% | |
| – | +13.1% | +32.8% | -53.0% | +39.8% | -15.8% | +36.6% | +145.4% | +66.3% | -15.9% | +8.9% | +171.6% | |
| – | -4.3% | -15.2% | -53.6% | +157.1% | -7.4% | +145.7% | +44.0% | +34.2% | -23.1% | -8.0% | -15.3% | |
| – | +5.4% | +17.5% | -99.8% | +28,762.7% | +7.1% | -44.0% | +73.4% | +360.7% | -24.8% | +10.2% | +130.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | +500.0% | +48.9% | -10.9% | -21.5% | -21.0% | -11.8% | +10.9% | +105.2% | -4.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -25.0% | -63.7% | +349.5% | -51.4% | -55.0% | -37.4% | +289.6% | -0.4% | +83.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.